Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$18.39
-0.11-0.59%
Last update: Oct 9, 4:00 PM
$18.46
-0.035-0.19%
Janux Therapeutics Inc (JANX) Stock Price, Quote, News & History
JANXNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Janux Therapeutics (NASDAQ:JANX) through any online brokerage.
Other companies in Janux Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Janux Therapeutics has a consensus price target of $47.45.
The stock price for Janux Therapeutics (NASDAQ: JANX) is $18.39 last updated October 9, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Janux Therapeutics.
Janux Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Janux Therapeutics.
Janux Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
